Drupal.behaviors.print = function(context) {window.print();window.close();}>
Colorado Study Yields miRNA Marker with Potential as a Surrogate Endpoint in Chemoprevention Trials
January 16, 2013
Colorado Study Yields miRNA Marker with Potential as a Surrogate Endpoint in Chemoprevention Trials
By
Molika Ashford
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Molika Ashford is a GenomeWeb contributing editor and covers personalized medicine and molecular diagnostics. E-mail
Molika Ashford
.
Related Stories
Theradiag Expanding microRNA Assay Plans with HIV, Anti-Obesity CDx Agreement
May 2, 2013 / Gene Silencing News
Posters at AACR Underscore Caris Life Sciences' miRNA Microvesicle Diagnostics Work
April 12, 2012 / Gene Silencing News
Danish Team Developing miRNA Signatures to Diagnose Skin Diseases
March 22, 2012 / Gene Silencing News
GenomeWeb Feature: The Rise of Lung Cancer Genetic Testing
May 8, 2013 / Pharmacogenomics Reporter
TCGA Data Yields miRNA/mRNA Signature with Promise as Breast Cancer Prognostic
May 2, 2013 / Gene Silencing News